Search filters

List of works by Hope Rugo

4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†

scientific article published on 01 August 2018

5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)†

scientific article published on 23 September 2020

A 4-Month Whole-Systems Ayurvedic Medicine Nutrition and Lifestyle Intervention Is Feasible and Acceptable for Breast Cancer Survivors: Results of a Single-Arm Pilot Clinical Trial

scientific article published on 01 December 2020

A Novel Strategy for Detection and Enumeration of Circulating Rare Cell Populations in Metastatic Cancer Patients Using Automated Microfluidic Filtration and Multiplex Immunoassay

scientific article published on 23 October 2015

A Pharmacogenetic Prediction Model of Progression-Free Survival in Breast Cancer using Genome-Wide Genotyping Data from CALGB 40502 (Alliance)

A Phase 2 Trial of Dasatinib in Patients with Advanced HER2-Positive and/or Hormone Receptor–Positive Breast Cancer ⬇️

scientific article published on September 8, 2011

A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline BRCA1/2 Mutations (ABRAZO)

scientific article published on 18 December 2018

A Review of NEPA, a Novel Fixed Antiemetic Combination with the Potential for Enhancing Guideline Adherence and Improving Control of Chemotherapy-Induced Nausea and Vomiting

scientific article

A Roundtable Discussion of the Breast Cancer Therapy Expert Group (BCTEG): Clinical Developments and Practice Guidance on Human Epidermal Growth Factor Receptor 2 (HER2)-positive Breast Cancer

scientific article published on 21 August 2019

A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxel.

scientific article

A clinician's guide to biosimilars in oncology

scientific article

A feasibility study of bevacizumab plus dose-dense doxorubicin-cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel in early-stage breast cancer

scientific article published on 24 February 2011

A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor malignancies.

scientific article published on 13 February 2016

A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinoma

scientific article published on 01 September 2019

A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer.

scientific article published on 21 March 2017

A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer ⬇️

scientific article published on December 24, 2011

A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007

scientific article published on 26 September 2014

A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer

scientific article

A phase II study of trastuzumab emtansine in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer who were previously treated with trastuzumab, lapatinib, an anthracycline, a taxane, and capecitabine

scientific article

A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer

scientific article published on December 2008

A population pharmacokinetic/pharmacodynamic model of thrombocytopenia characterizing the effect of trastuzumab emtansine (T-DM1) on platelet counts in patients with HER2-positive metastatic breast cancer ⬇️

scientific article published on August 12, 2012

A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer

scientific article

A randomized, double-blind, phase 2 study of ruxolitinib or placebo in combination with capecitabine in patients with advanced HER2-negative breast cancer and elevated C-reactive protein, a marker of systemic inflammation.

scientific article published on 19 April 2018

A randomized, phase II, dose-finding study of the pan-ErbB receptor tyrosine-kinase inhibitor CI-1033 in patients with pretreated metastatic breast cancer

scientific article published on 18 March 2009

A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer.

scientific article published on 7 May 2013

ATTAIN: Phase III study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer and brain metastases

scientific article published on 10 May 2019

Abstract OT1-02-07: SOPHIA: A phase 3, randomized study of margetuximab plus chemotherapy vs trastuzumab plus chemotherapy in the treatment of patients with HER2+ metastatic breast cancer

Abstract P2-11-04: Education and information preferences for women with triple-negative breast cancer: Should personal or medical demographic variables impact program tailoring?

Abstract P5-17-06: Emotional/psychological characteristics of women with triple-negative breast cancer: Do socioeconomic, demographic, and provider variables impact emotional change from diagnosis to post-treatment?

Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation

scientific article published in December 2004

Achieving Improved Survival Outcomes in Advanced Breast Cancer

scientific article published on 01 July 2019

Acupressure for Chemotherapy-Induced Nausea and Vomiting: A Randomized Clinical Trial

article by Suzanne Dibble et al published 1 July 2007 in Oncology Nursing Forum

Acupressure for chemotherapy-induced nausea and vomiting: a randomized clinical trial

scientific article

Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer

scientific article published on July 2016

Adaptive Trials in the Neoadjuvant Setting: A Model to Safely Tailor Care While Accelerating Drug Development

scientific article published on 20 December 2012

Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial

scientific article published on 28 February 2018

Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer ⬇️

scientific article

Advance Care Planning in Community: An Evaluation of a Pilot 2-Session, Nurse-Led Workshop

scientific article published on 28 August 2018

Advocacy spurs innovation: promoting synergy between physical and biomedical sciences

article

Alpelisib Plus Fulvestrant for PIK3CA-Mutated, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Advanced Breast Cancer: Final Overall Survival Results From SOLAR-1

scientific article published on 24 November 2020

Alpelisib Plus Fulvestrant in PIK3CA-Altered and PIK3CA-Wild-Type Estrogen Receptor-Positive Advanced Breast Cancer: A Phase 1b Clinical Trial

scientific article published on 14 February 2019

Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer

scientific article published on 01 May 2019

Amelioration of sexual adverse effects in the early breast cancer patient

scientific article

An open-label, phase 2 trial of RPI.4610 (Angiozyme) in the treatment of metastatic breast cancer.

scientific article published on 26 January 2012

Androgen receptor gene expression in primary breast cancer

scientific article published on 10 December 2019

Antiemesis

scientific article published on 01 April 2012

Antiemesis. Clinical Practice Guidelines in Oncology

scientific article published on May 2009

Assessing Clinical Equivalence in Oncology Biosimilar Trials With Time-to-Event Outcomes

scientific article published on 01 August 2019

Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer

scientific article

Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer

scientific article published on February 2017

Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical T

scientific article published on 23 July 2020

Association of tamoxifen use and ovarian function in patients with invasive or pre-invasive breast cancer

scientific article

Associations Between Pro- and Anti-Inflammatory Cytokine Genes and Breast Pain in Women Prior to Breast Cancer Surgery ⬇️

scientific article published on April 18, 2012

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial

scientific article published on 27 November 2019

Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report

scientific article published in November 1998

Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimen.

scientific article published in January 1993

Autologous stem cell transplantation for acute myeloid leukemia in first remission

scientific article published on January 2000

Baseline Characteristics, Treatment Patterns, and Outcomes in Patients with HER2-Positive Metastatic Breast Cancer by Hormone Receptor Status from SystHERs

scientific article published on 26 November 2019

Bevacizumab for advanced breast cancer

scientific article published on April 2007

Bevacizumab in the treatment of breast cancer: rationale and current data

scientific article

Biomarker Analyses of Response to Cyclin-Dependent Kinase 4/6 Inhibition and Endocrine Therapy in Women with Treatment-Naïve Metastatic Breast Cancer

scientific article published on 16 September 2019

Bisphosphonates and their impact on disseminated tumor cells in early stage breast cancer ⬇️

scientific article published on January 1, 2011

Brain metastases in breast cancer: clinical and pathologic characteristics associated with improvements in survival

scientific article published on 09 April 2008

Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

scientific article published on 01 April 2020

Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

scientific article published on 14 March 2017

Breast Conservation After Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Surgical Results From the BrighTNess Randomized Clinical Trial

scientific article published on 08 January 2020

Busulfan plus etoposide as a preparative regimen for autologous bone marrow transplantation for acute myelogenous leukemia: an update

scientific article published in August 1993

Cancer-Related Fatigue, Version 2.2015.

scientific article

Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer.

scientific article published on 5 November 2015

Case-Based Review and Clinical Guidance on the Use of Genomic Assays for Early-Stage Breast Cancer: Breast Cancer Therapy Expert Group (BCTEG)

scientific article published on 08 January 2020

Central Nervous System Metastasis in Patients with HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from SystHERs

scientific article published on 28 December 2018

Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHER.

scientific article

Challenging clinical scenarios: treatment of patients with triple-negative or basal-like metastatic breast cancer

scientific article published on September 2010

Change in topoisomerase 1 (Top1) positive circulating tumor cells impacts overall survival in patients with advanced breast cancer after treatment with etirinotecan pegol

scientific article published on 4 April 2018

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).

scientific article published on 25 December 2011

Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial).

scientific article published on 16 May 2015

Circulating Tumors Cells as a Biomarker of Radiation Benefit

scientific article published on 09 August 2018

Circulating tumor cell analysis in metastatic triple-negative breast cancers

scientific article published on 18 December 2014

Clinical and biomarker predictors of side effects from tamoxifen ⬇️

scientific article published on December 30, 2011

Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015

scientific article published on 06 May 2020

Clinical roundtable monograph. Current treatment options for metastatic breast cancer: what now?

scientific article published in November 2011

Clinical roundtable monograph: New data in emerging treatment options for chemotherapy-induced nausea and vomiting

scientific article

Clinical significance of circulating tumor cells in hormone receptor-positive metastatic breast cancer patients who received letrozole with or without bevacizumab

scientific article published on 25 June 2020

Combined peripheral natural killer cell and circulating tumor cell enumeration enhance prognostic efficiency in patients with metastatic triple-negative breast cancer

scientific article published on 01 June 2018

Comparative effectiveness analysis of monotherapy with cytotoxic agents in triple-negative metastatic breast cancer in a community setting

scientific article published on 26 November 2014

Concerns About Methodology of a Trial Investigating Vaginal Health During Aromatase Inhibitor Therapy for Breast Cancer-Reply

scientific article

Considerations for Use of Hematopoietic Growth Factors in Patients With Cancer Related to the COVID-19 Pandemic

scientific article published on 01 September 2020

Correlative Analysis of Genetic Alterations and Everolimus Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From BOLERO-2.

scientific article published on 26 October 2015

Cost comparison of capecitabine in patients with breast cancer

scientific article published in December 2010

Current treatment options for metastatic breast cancer: what now?

scientific article published on 01 November 2011

Cyclin-Dependent Kinase 4/6 Inhibitors for the Treatment of Breast Cancer: A Review of Preclinical and Clinical Data

scientific article

Cyclin-dependent kinase 4/6 inhibition in the treatment of hormone receptor-positive breast cancer

scientific article published on 01 October 2019

Cyclophosphamide, epirubicin, and Fluorouracil versus dose-dense epirubicin and cyclophosphamide followed by Paclitaxel versus Doxorubicin and cyclophosphamide followed by Paclitaxel in node-positive or high-risk node-negative breast cancer

scientific article

Cytoreduction of lymphoid malignancies and mobilization of blood hematopoietic progenitor cells with high doses of cyclophosphamide and etoposide plus filgrastim

scientific article published in March 2006

DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial

scientific article published on 25 August 2017

De Novo Versus Recurrent HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs Registry

scientific article published on 14 October 2019

Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemia.

scientific article published in January 1996

Demystifying biosimilars: development, regulation and clinical use

scientific article published on 30 November 2018

Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer

scientific article published on 31 October 2015

Developing Safety Criteria for Introducing New Agents into Neoadjuvant Trials ⬇️

scientific article published on March 7, 2013

Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction

scientific article published on 9 November 2009

Dosing and Safety Implications for Oncologists When Administering Everolimus to Patients With Hormone Receptor-Positive Breast Cancer

scientific article

Dual HER2 Blockade

scientific article

Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: results from a phase I study

scientific article

Early assessment with magnetic resonance imaging for prediction of pathologic response to neoadjuvant chemotherapy in triple-negative breast cancer: Results from the phase III BrighTNess trial

scientific article published on 05 October 2019

Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial

scientific article published on 13 February 2020

Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Randomized Clinical Trial.

scientific article published on December 2016

Effect of everolimus on bone marker levels and progressive disease in bone in BOLERO-2.

scientific article published on 19 February 2013

Effect of trastuzumab on health-related quality of life in patients with HER2-positive metastatic breast cancer: data from three clinical trials

scientific article

Effect of visceral metastases on the efficacy and safety of everolimus in postmenopausal women with advanced breast cancer: subgroup analysis from the BOLERO-2 study

scientific article published in June 2013

Efficacy and Safety of Ixabepilone and Capecitabine in Patients With Advanced Triple-negative Breast Cancer: a Pooled Analysis From Two Large Phase III, Randomized Clinical Trials

scientific article published on 04 August 2018

Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer

scientific article published on 25 August 2019

Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE-158 and KEYNOTE-028 studies

scientific article published on 02 May 2020

Efficacy of NEPA (netupitant/palonosetron) across multiple cycles of chemotherapy in breast cancer patients: A subanalysis from two phase III trials

scientific article published on 9 March 2017

Emerging data on improving response to hormone therapy: the role of novel targeted agents

scientific article published in December 2017

Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer

scientific article

Emerging treatments in chemotherapy-induced nausea and vomiting

scientific article published on February 1, 2013

Endocrine Therapy for Hormone Receptor Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline Summary

scientific article published on 24 May 2016

Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline

scientific article published on 23 May 2016

Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG).

scientific article published on 19 January 2018

Erratum to: Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis.

scientific article published on 11 September 2014

Erratum to: Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy

scientific article published on 28 June 2017

Erratum to: Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial.

scientific article published on 7 September 2017

Etirinotecan pegol (NKTR-102) versus treatment of physician's choice in women with advanced breast cancer previously treated with an anthracycline, a taxane, and capecitabine (BEACON): a randomised, open-label, multicentre, phase 3 trial.

scientific article published on 15 October 2015

Everolimus and Its Role in Hormone-Resistant and Trastuzumab-Resistant Metastatic Breast Cancer ⬇️

scientific article published on November 1, 2012

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer

scientific article (publication date: 9 February 2012)

Everolimus plus exemestane as first-line therapy in HR⁺, HER2⁻ advanced breast cancer in BOLERO-2.

scientific article published on 21 December 2013

Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2†.

scientific article published on 17 September 2014

Everolimus plus exemestane in postmenopausal patients with HR(+) breast cancer: BOLERO-2 final progression-free survival analysis

scientific article published on 25 October 2013

Evidence-driven, patient-specific approaches for optimizing survival prolongation in breast cancer

scientific article published on August 2014

Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer

scientific article published on 17 July 2020

Expanded genomic profiling of circulating tumor cells in metastatic breast cancer patients to assess biomarker status and biology over time

scientific article published on 8 January 2018

Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials

scientific article published on 16 February 2017

Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancer

scientific article published on 19 October 2009

Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy

scientific article published on 13 May 2017

Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial

scientific article published on 06 October 2020

First-Line Treatment Patterns and Clinical Outcomes in Patients With HER2-Positive and Hormone Receptor-Positive Metastatic Breast Cancer From registHER ⬇️

scientific article published on May 7, 2013

Fitbit Usage in Patients With Breast Cancer Undergoing Chemotherapy

scientific article published on 25 May 2019

Fixed combination of oral NEPA (netupitant-palonosetron) for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in patients receiving multiple cycles of chemotherapy: Efficacy data from 2 randomized, double-blind phase III

scientific article published on 09 April 2019

Genome-Wide Meta-Analysis Validates a Roless for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy

scientific article published on 20 June 2020

Genomic and expression profiling reveal molecular heterogeneity of disseminated tumor cells in bone marrow of early breast cancer

Genomic profiling of isolated circulating tumor cells from metastatic breast cancer patients

scientific article

Geographic Variation in Postoperative Imaging for Low-Risk Breast Cancer

scientific article published on 01 July 2018

Geographic and Patient Characteristics Associated With Election of Prophylactic Mastectomy in Young Breast Cancer Patients With Early Disease

scientific article published on 01 November 2018

Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study

scientific article published on 01 July 2020

HER2-positive breast cancer: is more treatment better?

scientific article published on 10 February 2016

Health-related quality of life and disease symptoms in postmenopausal women with HR(+), HER2(-) advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy

scientific article published on 4 September 2013

Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial ⬇️

scientific article

Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial

scientific article published on 15 March 2013

Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies

scientific article published on 12 March 2020

High-dose chemotherapy (CTM) for breast cancer

scientific article published on August 2000

High-dose chemotherapy for peripheral stem cell procurement in leukemia, lymphoma and multiple myeloma.

scientific article published in January 1994

High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency

scientific article published on February 1997

High-dose etoposide, thiotepa, and dose-adjusted carboplatin (TVCa) with autologous hematopoietic stem cell rescue as treatment of relapsed or refractory germ cell cancer

scientific article published in April 2005

Highlights from the 2019 San Antonio Breast Cancer Symposium

scientific article published on 01 March 2020

Highlights in breast cancer from the 2016 American Society of Clinical Oncology Annual Meeting

scientific article

Highlights in breast cancer from the 2017 American Society of Clinical Oncology Annual Meeting

scientific article published in August 2017

Highlights in breast cancer from the 2018 American Society of Clinical Oncology annual meeting

scientific article published on 01 August 2018

Hormonal therapy for advanced breast cancer

scientific article published on April 2007

Hormone therapy in premenopausal women with early-stage breast cancer

scientific article published in July 2014

Human epidermal growth factor receptor 2 positive (HER2+) metastatic breast cancer: how the latest results are improving therapeutic options

scientific article

Identification of a Genomic Region between and Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance)

scientific article published on 05 June 2018

Identifying tests related to breast cancer care in claims data

scientific article published on 18 November 2019

Immune microenvironments in solid tumors: new targets for therapy

scientific article published on December 2011

Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer

scientific article published on 11 January 2011

Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study ⬇️

scientific article published on October 1, 2012

Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial

scientific article published on 19 January 2018

Implementing decision and communication aids to facilitate patient-centered care in breast cancer: a case study

scientific article published on 21 October 2009

Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: diarrheal toxicity in the CONTROL trial

scientific article published on 25 May 2020

Improving Response to Hormone Therapy in Breast Cancer: New Targets, New Therapeutic Options

scientific article published on January 2016

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

scientific article published on 23 July 2015

Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2.

scientific article published on 10 March 2014

Inhibiting Angiogenesis in Breast Cancer: The Beginning of the End or the End of the Beginning? ⬇️

scientific article published on February 13, 2012

Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance).

scientific article published on 15 June 2017

Lapatinib: new directions in HER2 directed therapy for early stage breast cancer

scientific article published on January 2009

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy

scientific article (publication date: June 2011)

Leukocyte composition of human breast cancer

scientific article published on 8 August 2011

Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial)

scientific article published on 19 April 2019

Long-term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for HR+/HER2- Advanced Breast Cancer.

scientific article

Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER.

scientific article

MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial

scientific article published on 07 February 2019

MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2- Metastatic Breast Cancer

scientific article published on 22 May 2017

MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival

scientific article

MYC Dysregulates Mitosis, Revealing Cancer Vulnerabilities

scientific article published on 01 March 2020

Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells

scientific article

Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3

scientific article published on 21 September 2020

Management of Cancer Cachexia: ASCO Guideline

scientific article published on 20 May 2020

Management of breast cancer diagnosed during pregnancy

scientific article

Management of chemotherapy-induced nausea and vomiting in clinical practice

Meta-analysis of stomatitis in clinical studies of everolimus: incidence and relationship with efficacy.

scientific article published on 11 January 2016

Methylome Variation Predicts Exemestane Resistance in Advanced ER+ Breast Cancer

scientific article published on 01 January 2020

Mitotic score and pleomorphic histology in invasive lobular carcinoma of the breast: impact on disease-free survival

scientific article published on 02 April 2020

Most neoadjuvant chemotherapy for triple-negative breast cancer should include platinum

scientific article published on 01 January 2021

Myeloid Growth Factors, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

scientific article published in December 2017

Myeloid growth factors

scientific article published on 01 October 2013

NCCN Clinical Practice Guidelines Cancer-related fatigue

scientific article

NCCN Guidelines Insights: Antiemesis, Version 2.2017.

scientific article

NCCN Guidelines Insights: Breast Cancer, Version 3.2018

scientific article published on 01 February 2019

NCCN Guidelines Insights: Hematopoietic Growth Factors, Version 1.2020

scientific article published on 01 January 2020

NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016.

scientific article

NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results of a randomized, double-blind, phase 3 trial versus oral palonosetron

scientific article

Neoadjuvant therapy for HER2-positive early-stage breast cancer: the future is almost here

scientific article published on January 1, 2012

New and emerging therapeutic options for the management of chemotherapy-induced nausea and vomiting

New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer

scientific article published on 21 October 2008

New developments in metastatic breast cancer: general discussion

scientific article published in January 2013

New developments in metastatic breast cancer: integrating recent data into clinical practice

scientific article

New developments in metastatic breast cancer: introduction

scientific article published in January 2013

New frontiers and treatment paradigms for metastatic breast cancer. A Review of an adjunct symposium of the 2011 American Society of Clinical Oncology Annual Meeting, June 4, 2011 Chicago, Illinois

scientific article published on August 1, 2011

Novel Therapeutic Interventions Early in the Disease Trajectory: Drug Development Beyond the Refractory Setting

scientific article published on 22 June 2020

Novel taxane formulations in the treatment of breast cancer: a thought leader discussion and consensus roundtable

scientific article published on February 2008

Oncological care organisation during COVID-19 outbreak

scientific article published on 01 August 2020

Oncologist use of the Adjuvant! model for risk communication: a pilot study examining patient knowledge of 10-year prognosis

scientific article

Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice

scientific article

Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study

scientific article

Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician's Choice Standard-of-Care Chemotherapy

scientific article published on 21 October 2019

Overall Survival Benefit With Lapatinib in Combination With Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Final Results From the EGF104900 Study ⬇️

scientific article published on June 11, 2012

PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression

scientific article published on 24 October 2016

Paclitaxel poliglumex. Cell Therapeutics/Chugai Pharmaceutical.

scientific article

Palbociclib and Letrozole in Advanced Breast Cancer

scientific article published on November 2016

Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer

scientific article

Palbociclib in Combination With Fulvestrant in Women With Hormone Receptor-Positive/HER2-Negative Advanced Metastatic Breast Cancer: Detailed Safety Analysis From a Multicenter, Randomized, Placebo-Controlled, Phase III Study (PALOMA-3).

scientific article published on July 2016

Palbociclib plus endocrine therapy in older women with HR+/HER2- advanced breast cancer: a pooled analysis of randomised PALOMA clinical studies

scientific article published on 25 July 2018

Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up

Palbociclib with Letrozole in Postmenopausal Women with ER+/HER2- Advanced Breast Cancer: Hematologic Safety Analysis of the Randomized PALOMA-2 Trial

scientific article published on 19 June 2019

Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657.

scientific article

Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers

scientific article

Patient perceptions of reproductive health counseling at the time of cancer diagnosis: a qualitative study of female California cancer survivors

scientific article published on 3 July 2012

Patient-reported outcomes from the phase III IMpassion130 trial of atezolizumab plus nab-paclitaxel in metastatic triple-negative breast cancer

scientific article published on 20 February 2020

Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study

scientific article published on 01 March 2019

Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study

scientific article published on 01 March 2019

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

scientific article published on 01 December 2020

Personalized Management of Chemotherapy-Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance)

scientific article published on 04 December 2019

Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment ⬇️

scientific article published on October 4, 2011

Phase 2 study of pembrolizumab (pembro) monotherapy for previously treated metastatic triple-negative breast cancer (mTNBC): KEYNOTE-086 cohort A

Phase I dose-escalation and expansion study of PARP inhibitor, fluzoparib (SHR3162), in patients with advanced solid tumors

scientific article published on 01 June 2020

Phase I dose-escalation study of 5-day intermittent oral lapatinib therapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer

scientific article

Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer

scientific article

Phase I trial of the oral antiangiogenesis agent AG-013736 in patients with advanced solid tumors: pharmacokinetic and clinical results

scientific article

Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer ⬇️

scientific article published on August 21, 2013

Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer

scientific article published on 20 April 2009

Phase II study of irinotecan and temozolomide in breast cancer patients with progressing central nervous system disease

scientific article published on 06 June 2019

Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane

scientific article

Phase II study of the antibody drug conjugate trastuzumab-DM1 for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer after prior HER2-directed therapy

scientific article

Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance)

scientific article published on 02 May 2016

Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.

scientific article

Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors.

scientific article published on 21 June 2019

Phosphatidylinositol 3-Kinase α-Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study

scientific article published on 5 February 2018

Phosphoinositide 3-kinase inhibition in the treatment of hormone receptor-positive breast cancer

scientific article published on 01 September 2019

Planning for post-pandemic cancer care delivery: Recovery or opportunity for redesign?

scientific article published on 30 September 2020

Plasma PIK3CA ctDNA specific mutation detected by next generation sequencing is associated with clinical outcome in advanced breast cancer

article published in 2018

Post-remission cytopenias following intense induction chemotherapy for acute myeloid leukemia.

scientific article

Practice patterns in the delivery of radiation therapy after mastectomy among the University of California Athena Breast Health Network

scientific article published on 15 August 2014

Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial

scientific article

Proceedings of the First Global Workshop on Breast Cancer: Pathways to the Evaluation and Clinical Development of Novel Agents for Breast Cancer ⬇️

scientific article published on December 1, 2010

Prognostic Value of Plasma HER2 Gene Copy Number in HER2-Positive Metastatic Breast Cancer Treated with First-Line Trastuzumab

scientific article published on 19 May 2020

Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial

scientific article published on January 2015

Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer

scientific article published on 2 April 2015

Progress against solid tumors in danger: the metastatic breast cancer example

scientific article published on 27 August 2012

Progression-free Survival Outcome Is Independent of Objective Response in Patients With Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer Treated With Palbociclib Plus Letrozole Compared With Letroz

scientific article published on 05 September 2019

Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial.

scientific article published on 13 June 2017

Quality of life with talazoparib after platinum or multiple cytotoxic non-platinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations: patient-reported outcomes from the ABRAZO phase 2 trial

scientific article published on 22 October 2018

Quality of life with talazoparib versus physician's choice of chemotherapy in patients with advanced breast cancer and germline BRCA1/2 mutation: patient-reported outcomes from the EMBRACA phase III trial

scientific article published on 01 September 2018

Quantitative Whole Genome Sequencing of Circulating Tumor Cells Enables Personalized Combination Therapy of Metastatic Cancer

scientific article published on August 2017

Quantitative and clinical description of postural instability in women with breast cancer treated with taxane chemotherapy

scientific article published on 01 August 2007

RIBBON-2: a randomized, double-blind, placebo-controlled, phase III trial evaluating the efficacy and safety of bevacizumab in combination with chemotherapy for second-line treatment of human epidermal growth factor receptor 2-negative metastatic br

scientific article published on October 11, 2011

Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancer

scientific article published on 24 September 2013

Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NC

scientific article published on 8 June 2015

Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer

scientific article

Randomized study of Lapatinib alone or in combination with trastuzumab in women with ErbB2-positive, trastuzumab-refractory metastatic breast cancer

scientific article

Randomized, placebo-controlled, double-blind, phase II study of axitinib plus docetaxel versus docetaxel plus placebo in patients with metastatic breast cancer.

scientific article published on 9 May 2011

Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2-metastatic breast cancer receiving single-agent chemotherapy-a comparison with MONARCH 1

scientific article published on 12 August 2020

Real-world use of scalp cooling to reduce chemotherapy-related hair loss.

scientific article published in November 2017

Receptor activator of nuclear factor kappa B (RANK) expression in primary breast cancer correlates with recurrence-free survival and development of bone metastases in I-SPY1 (CALGB 150007/150012; ACRIN 6657).

scientific article published on 2 June 2017

Reducing the Long-term Effects of Chemotherapy in Young Women With Early-Stage Breast Cancer ⬇️

scientific article published on July 20, 2011

Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy

scientific article published on 18 September 2017

Reply to the letter to the editor 'Everolimus, when combined with exemestane, adds toxicity with minimal benefit for women with breast cancer' Tannock and Pond

scientific article

Reply to the letter to the editor 'Reporting of HRQoL results from the PALOMA-2 trial: unfounded conclusions due to highly biased analyses' by Kaiser et al

scientific article published on 01 August 2018

Response of Brain Metastases From PIK3CA-Mutant Breast Cancer to Alpelisib

scientific article published on 27 May 2020

Reversing Hormone Resistance: Have We Found the Golden Key? ⬇️

scientific article published on 02 July 2012

Risk communication with patients with breast cancer: cautionary notes about printing Adjuvant! estimates.

scientific article

Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience

scientific article

SIS.NET: a randomized controlled trial evaluating a web-based system for symptom management after treatment of breast cancer

scientific article

SOPHIA: A phase 3, randomized study of margetuximab (M) plus chemotherapy (CTX) vs trastuzumab (T) plus CTX in the treatment of patients with HER2+ metastatic breast cancer (MBC)

Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer

scientific article published on 01 February 2019

Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results From the KEYNOTE-028 Study

scientific article published on 10 May 2017

Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen Receptor‒Positive/Human Epidermal Growth Factor Receptor 2‒Negative Advanced Breast Cancer.

scientific article published on 20 March 2018

Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1-Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial.

scientific article published on 2 November 2017

Safety and efficacy of everolimus with exemestane vs. exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2.

scientific article

Safety and tolerability of etirinotecan pegol in advanced breast cancer: analysis of the randomized, phase 3 BEACON trial ⬇️

scientific article published on 08 July 2016

Scalp Hypothermia for Preventing Alopecia During Chemotherapy. A Systematic Review and Meta-Analysis of Randomized Controlled Trials

scientific article published on 10 August 2017

Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis

scientific article

Second-line bevacizumab-containing therapy in patients with triple-negative breast cancer: subgroup analysis of the RIBBON-2 trial ⬇️

scientific article published on March 14, 2012

Senior adult oncology

scientific article published on February 2012

Senior adult oncology, version 2.2014: clinical practice guidelines in oncology

Serial analysis of circulating tumor cells in metastatic breast cancer receiving first-line chemotherapy

scientific article published on 08 August 2020

Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and response

scientific article published on 29 May 2015

Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

scientific article published on 02 April 2019

Sorafenib or Placebo with Either Gemcitabine or Capecitabine in Patients with HER-2–Negative Advanced Breast Cancer That Progressed during or after Bevacizumab ⬇️

scientific article published on February 26, 2013

Special report: Consensus conference III. Image-detected breast cancer: state-of-the-art diagnosis and treatment

scientific article published on 20 August 2009

Still Refining Adjuvant Endocrine Therapy in Premenopausal Women: Not Too Much, Not Too Little

scientific article published on 16 May 2016

Stomatitis associated with mammalian target of rapamycin inhibition: A review of pathogenesis, prevention, treatment, and clinical implications for oral practice in metastatic breast cancer

scientific article published on 10 February 2018

Strategic Combinations to Prevent and Overcome Resistance to Targeted Therapies in Oncology

scientific article published on 01 May 2020

Strategies and Progress of Endocrine Therapy for Patients with Metastatic Breast Cancer

scientific article published in January 2017

Strategies for the prevention of treatment-related bone loss in women receiving adjuvant hormonal therapy.

scientific article published on July 2007

Studying cancer-related fatigue: report of the NCCN scientific research committee.

scientific article published on December 2010

Synchronous Breast Implant-associated Anaplastic Large Cell Lymphoma and Invasive Carcinoma: Genomic Profiling and Management Implications

scientific article published on 04 April 2019

Systemic treatment of early breast cancer—a biological perspective ⬇️

scientific article published on May 1, 2011

T-Cell-Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028

scientific article published on 13 December 2018

TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer

scientific article

TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer

scientific article published on 18 February 2020

TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer.

scientific article published on 16 March 2015

TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer

scientific article

TIM-3 Regulates CD103+ Dendritic Cell Function and Response to Chemotherapy in Breast Cancer

scientific article

TROPiCS-02: A Phase III study investigating sacituzumab govitecan in the treatment of HR+/HER2- metastatic breast cancer

scientific article published on 30 March 2020

Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation

scientific article published on 15 August 2018

Talazoparib in Patients with a Germline BRCA-Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial

scientific article published on 25 November 2019

Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial

scientific article published on 20 August 2020

Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer

scientific article

Targeting growth factors and angiogenesis; using small molecules in malignancy

scientific article published on June 2006

Targeting the host immune system: PD-1 and PD-L1 antibodies and breast cancer

scientific article published on 15 October 2016

The DigniCap Scalp Cooling System and its use in the treatment of chemotherapy-induced alopecia

scientific article published on 12 July 2018

The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer

scientific article published on 24 February 2015

The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review

scientific article published on 22 May 2020

The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer

scientific article

The cancer glycocalyx mechanically primes integrin-mediated growth and survival

scientific article

The cardiac safety of trastuzumab in the treatment of breast cancer

scientific article published on March 2010

The characterization, management, and future considerations for ErbB-family TKI-associated diarrhea

scientific article published on 22 January 2019

The impact of 5-hydroxytryptamine-receptor antagonists on chemotherapy treatment adherence, treatment delay, and nausea and vomiting

scientific article published on 16 June 2015

The impact of adjuvant therapy for breast cancer on cognitive function: current evidence and directions for research

scientific article published on December 2003

The impact of an electronic health questionnaire on symptom management and behavior reporting for breast cancer survivors ⬇️

scientific article published on July 15, 2012

The impact of sharing results of a randomized breast cancer clinical trial with study participants

scientific article published on 10 June 2008

The importance of distant metastases in hormone-sensitive breast cancer

scientific article published on January 2008

The new world of biosimilars in oncology: Translation of data to the clinic

scientific article published on 18 April 2018

The role of angiogenesis inhibition in the treatment of breast cancer

scientific article published on October 2006

The role of endoscopic evaluation in patients with suspected intestinal graft-versus-host disease after allogeneic bone-marrow transplantation

scientific article published on October 1996

The role of targeted therapy and biomarkers in breast cancer treatment ⬇️

scientific article published on June 13, 2012

The role of trastuzumab in early stage breast cancer: current data and treatment recommendations

scientific article

The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression

scientific article

The value of embedding: integrated palliative care for patients with metastatic breast cancer.

scientific article published on 30 October 2017

Time Course and Management of Key Adverse Events During the Randomized Phase 3 SOLAR-1 Study of PI3K Inhibitor Alpelisib Plus Fulvestrant in Patients With HR-Positive Advanced Breast Cancer

scientific article published on 13 May 2020

Time to Adjuvant Chemotherapy for Breast Cancer in National Comprehensive Cancer Network Institutions ⬇️

scientific article published on December 21, 2012

Translating the molecular message of triple-negative breast cancer into targeted therapy

scientific article published on 28 October 2014

Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 and PALOMA-3 clinical trials

scientific article published on 11 August 2020

Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule

scientific article

Treatment of early-stage hormone receptor-positive breast cancer

scientific article published on 01 November 2019

Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancer

scientific article

Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational study ⬇️

scientific article published on August 26, 2012

Trends in the use of mastectomy in women with small node-negative breast cancer treated at US academic centers

scientific article

Triple-negative breast cancer: role of antiangiogenic agents

scientific article published on January 2010

Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer

scientific article

Tyrosine Kinase Inhibitors for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Is Personalizing Therapy Within Reach?

scientific article published on 7 August 2017

Understanding the Role of Comparative Clinical Studies in the Development of Oncology Biosimilars

scientific article published on 14 February 2020

Use of Neoadjuvant Platinum-The Ongoing Conundrum

scientific article published on 13 July 2017

Using diagnosis codes in claims data to identify cohorts of breast cancer patients following initial treatment

scientific article published on 20 January 2020

Utility of patient-derived lymphoblastoid cell lines as an ex vivo capecitabine sensitivity prediction model for breast cancer patients.

scientific article published on 20 May 2016

Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer: A Randomized Clinical Trial

scientific article

Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional study

scientific article published on 10 March 2015

When to Treat, With What, and for How Long: That Is the Question!

scientific article published in November 2016

Paulina is supported by:

About Paulina

Help